- Trials with a EudraCT protocol (302)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (17)
302 result(s) found for: Back pain.
Displaying page 1 of 16.
EudraCT Number: 2015-000751-25 | Sponsor Protocol Number: AXS02II201501 | Start Date*: 2016-05-02 | |||||||||||
Sponsor Name:Jaro Karppinen | |||||||||||||
Full Title: ZOLEDRONIC ACID, A LONG-ACTING BISPHOSPHONATE, FOR CHRONIC LOW BACK PAIN DUE TO MODIC CHANGES: A RANDOMIZED CONTROLLED TRIAL | |||||||||||||
Medical condition: Chronic low back pain | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-005722-35 | Sponsor Protocol Number: H--6-2014-070 | Start Date*: 2015-06-23 | ||||||||||||||||
Sponsor Name:Glostrup University Hospital | ||||||||||||||||||
Full Title: Measures of inflammation in low back pain (LBP) and anti-TNFα for the treatment of deemed discogenic LBP - an explorative study | ||||||||||||||||||
Medical condition: Low back pain with and without legg-pain In the late periode 1990ies it became clear that various cytokines and other inflammatory elements played a large role for low back pain. One of the known ... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-006042-13 | Sponsor Protocol Number: MEDI-TOLP-01 | Start Date*: 2022-03-28 | |||||||||||
Sponsor Name:MEDITOP Gyógyszeripari Kft. | |||||||||||||
Full Title: A randomized double blind placebo controlled multicenter study to assess the efficacy and tolerability of tolperisone as add on treatment with standardized NSAID of acute non specific low back pain. | |||||||||||||
Medical condition: Acute, non-specific low back pain | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002875-20 | Sponsor Protocol Number: KCT03/2015–DORETA | Start Date*: 2016-06-24 | |||||||||||
Sponsor Name:Krka, d.d., Novo mesto | |||||||||||||
Full Title: Efficacy and Safety of Prolonged Release (SR) Tramadol Hydrochloride (HCl)/Paracetamol fixed combination and Immediate Release (IR) Tramadol HCl/Paracetamol fixed combination in Patients with Moder... | |||||||||||||
Medical condition: Moderate to severe acute low-back pain (12 weeks or less of symptoms). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SI (Completed) CZ (Completed) HR (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-013268-38 | Sponsor Protocol Number: FLUPI-7018 | Start Date*: 2009-09-29 | |||||||||||
Sponsor Name:AWD.pharma GmbH & Co KG | |||||||||||||
Full Title: A multicentre, double-blind, randomised, active- and placebo-controlled clinical trial on the pain relieving effects of the modfied-release formulation of flupirtine in patients suffering from mode... | |||||||||||||
Medical condition: chronic low back pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-005259-28 | Sponsor Protocol Number: LCAT | Start Date*: 2016-02-22 | ||||||||||||||||
Sponsor Name:LUMC | ||||||||||||||||||
Full Title: A randomized, double blind, placebo-controlled study on the effect of 3 months treatment with the analgesic tapentadol on conditioned pain modulation (CPM) and pain relief in patients with chronic ... | ||||||||||||||||||
Medical condition: Low back pain | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002476-24 | Sponsor Protocol Number: EP-DICLO-TIO/F-01-2015 | Start Date*: 2015-10-13 | |||||||||||
Sponsor Name:Epifarma S.r.l. | |||||||||||||
Full Title: Randomized, double-blind, parallel-groups, active-controlled trial to evaluate the efficacy of a fixed combination of diclofenac 75 mg + thiocolchicoside 4 mg as solution for injection, in improvin... | |||||||||||||
Medical condition: low back pain | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-004530-29 | Sponsor Protocol Number: BECRO/WM/PAIN | Start Date*: 2018-01-23 | |||||||||||
Sponsor Name:WinMedica SA | |||||||||||||
Full Title: A Randomized, Multicentre, Double-blind, two Parallel Group, Clinical Phase III Trial for Comparing the Efficacy and Tolerability of a combination IM product of Thiocolchicoside and Diclofenac vs. ... | |||||||||||||
Medical condition: Acute low back pain (LBP) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-005495-34 | Sponsor Protocol Number: A4091059 | Start Date*: 2016-01-25 | |||||||||||
Sponsor Name:Pfizer Inc, 235 East 42nd Street, New York, NY 10017 | |||||||||||||
Full Title: A PHASE 3, RANDOMIZED, DOUBLE BLIND, PLACEBO AND ACTIVE-CONTROLLED, MULTICENTER, PARALLEL-GROUP STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF TANEZUMAB IN ADULT SUBJECTS WITH CHRONIC LOW BACK PAIN | |||||||||||||
Medical condition: CHRONIC LOW BACK PAIN | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) HU (Completed) DK (Prematurely Ended) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001920-36 | Sponsor Protocol Number: KF6005/06 | Start Date*: 2012-09-21 | |||||||||||
Sponsor Name:Grünenthal GmbH | |||||||||||||
Full Title: Efficacy, safety, and tolerability of GRT6005 in subjects with moderate to severe chronic low back pain | |||||||||||||
Medical condition: moderate to severe chronic low back pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) DE (Completed) BE (Completed) GB (Completed) ES (Completed) SE (Completed) DK (Completed) HU (Completed) FI (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-001742-29 | Sponsor Protocol Number: XIL02/15 | Start Date*: 2015-08-25 | |||||||||||
Sponsor Name:INDENA S.P.A. | |||||||||||||
Full Title: Tolerability, safety and activity of IDN5243, 4 mg bid intramuscularly in the treatment of low back pain. A prospective, open label, single-center, uncontrolled study. | |||||||||||||
Medical condition: Low Back Pain. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-003040-12 | Sponsor Protocol Number: TZSA2 | Start Date*: 2014-10-02 | |||||||||||
Sponsor Name:MDM S.p.A. | |||||||||||||
Full Title: A phase III, multicenter, randomized, parallel groups study to assess the efficacy and safety of 0,5 mg Tizaspray® administered intranasally versus Sirdalud® 2 mg tablets, in patients with acute lo... | |||||||||||||
Medical condition: Acute low back pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-000682-50 | Sponsor Protocol Number: REGO2013-592 | Start Date*: 2014-11-21 | |||||||||||
Sponsor Name:University Hospitals Coventry and Warwickshire NHS Trust [...] | |||||||||||||
Full Title: Facet-joint injections for people with persistent non-specific low back pain (FIS) | |||||||||||||
Medical condition: Facet Joint Pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003484-31 | Sponsor Protocol Number: F1J-MC-HMEN | Start Date*: 2006-12-13 | |||||||||||
Sponsor Name:Eli Lilly and Company Ltd. | |||||||||||||
Full Title: Effect of Duloxetine 60 mg to 120 mg Once Daily in Patients with Chronic Low Back Pain | |||||||||||||
Medical condition: Chronic Low Back Pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) FR (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-010428-25 | Sponsor Protocol Number: KF5503/45 | Start Date*: 2010-02-15 | |||||||||||
Sponsor Name:Grünenthal GmbH | |||||||||||||
Full Title: An evaluation of the effectiveness and tolerability of tapentadol hydrochloride prolonged release, and tapentadol hydrochloride immediate release on demand, in subjects with severe chronic nocicept... | |||||||||||||
Medical condition: Low back Pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) NL (Completed) DE (Completed) FR (Completed) BE (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004564-55 | Sponsor Protocol Number: COSTAL-2013 | Start Date*: 2014-03-10 | |||||||||||
Sponsor Name:MEDITOP Gyógyszeripari Kft | |||||||||||||
Full Title: A randomized, multicenter, double-blind, placebo controlled, parallel study to assess the efficacy and safety of the combined administration of sertraline and lamotrigine in subjects with chronic l... | |||||||||||||
Medical condition: Chronic low back pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) RO (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005278-86 | Sponsor Protocol Number: 147(Z)WO20157 | Start Date*: 2021-06-14 | ||||||||||||||||
Sponsor Name:AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. | ||||||||||||||||||
Full Title: Efficacy and safety of the combination of ibuprofen and paracetamol versus ibuprofen in monotherapy in acute Low Back Pain (LBP) | ||||||||||||||||||
Medical condition: Low Back Pain (LBP) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Completed) PL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-002943-11 | Sponsor Protocol Number: KF5503/60 | Start Date*: 2013-02-25 | ||||||||||||||||
Sponsor Name:Grünenthal GmbH | ||||||||||||||||||
Full Title: Evaluation of the effectiveness, safety, and tolerability of tapentadol PR versus oxycodone/naloxone PR in non-opioid pre-treated subjects with uncontrolled severe chronic low back pain with a neur... | ||||||||||||||||||
Medical condition: Severe chronic low back pain with a neuropathic pain component | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) IT (Completed) AT (Completed) ES (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-009857-17 | Sponsor Protocol Number: 42160443PAI2003 | Start Date*: 2009-12-16 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Dose-Loading Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42160443 as Adjunctive Therapy in Subjects With Inadequate... | |||||||||||||
Medical condition: Moderate to severe, chronic, low back pain (LBP) that is not adequately controlled by standard pain therapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-000724-37 | Sponsor Protocol Number: EP-DIC-TIO/75+4-F-01-2022 | Start Date*: 2022-11-08 | ||||||||||||||||
Sponsor Name:EPIFARMA S.R.L. | ||||||||||||||||||
Full Title: Randomized, double-blind, parallel-groups, active - and placebo-controlled study to Evaluate the efficacy of a fixed combination of diclofenac 75 mg + thiocolchicoside 4 mg as solution for injectio... | ||||||||||||||||||
Medical condition: Low back pain (LBP) is one of the most frequent and disabling health problems. It is estimated that about 80% of adults will experience an episode of acute or chronic LBP at least once during their... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Trial now transitioned) GR (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
